title: [Pulmonary infections after lung transplantation].
abstract: Lung transplantation has become an accepted therapeutic modality for end-stage diseases of the lungs and the pulmonary circulation. In the past two decades more than 20,000 lung transplantations were performed all over the world. Due to improvements in immunosuppressive regimens the mortality rate of severe acute rejections has decreased up to 2% in the first post-transplant year. By contrast, infections became the most common cause of morbidity and mortality after lung transplantation. It was reported that 21.2 and 40% of annual deaths are due to infections in the first 30 days and one year, respectively. In the first month 35-70% of transplant recipients develop bacterial pneumonia caused often by Gram-negative organisms especially by Pseudomonas species. All patients should receive prophylactic antibiotics after the operation, which are to be modified according to the resistance patterns of pathogens isolated from the donor lungs. In the early post-operative period, the frequency of invasive fungal (Aspergillus and Candida) and cytomegalovirus (CMV) infections appears to be less then 10% due to prophylactic amphotericin inhalation and systemic valganciclovir administration for 100 days. After withdrawing these drugs, these infections became more common. In the late post-transplant period, the development of bronchiolitis obliterans syndrome (BOS) may predispose to infections. BOS may be manifested in approximately 50% of patients 5 years post-transplant. Routinely or urgently performed screening tests (laboratory and radiological investigations, lung function tests, sputum culture, bronchoscopy) and specific treatments are of central importance in the management of infections. In this review we discuss the clinical manifestation, the diagnosis and the treatment possibilities of the most common pulmonary infections in lung transplant recipients.
authors.affiliation: Országos Korányi Tbc- és Pulmonológiai Intézet III. Tüdobelosztály, Budapest. czebekrisztina@freemail.hu
authors.forename: Krisztina
authors.initials: K
authors.lastname: Czebe
authors.forename: Balázs
authors.initials: B
authors.lastname: Antus
authors.forename: Marina
authors.initials: M
authors.lastname: Varga
authors.forename: Eszter
authors.initials: E
authors.lastname: Csiszér
mesh_terms: D019072:Antibiotic Prophylaxis; D004352:Drug Resistance, Microbial; D006801:Humans; D015994:Incidence; D008172:Lung Diseases, Fungal / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D008174:Lung Diseases, Parasitic / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000469:parasitology / Q000517:prevention & control; D016040:Lung Transplantation / Q000009:adverse effects*; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D011024:Pneumonia, Viral / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control / Q000821:virology; D012307:Risk Factors